1. A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain. (26th July 2019) Authors: Tadmor, Tamar; Braester, Andrei; Najib, Dally; Aviv, Ariel; Herishanu, Yair; Yuklea, Mona; Shvidel, Lev; Rahimi‐Levene, Naomi; Ruchlemer, Rosa; Arad, Ariela; Fogl, Claudia; Henig, Clara; Barak, Mira; Magal, Lee; Polliack, Aaron; Townsend, Kelly Journal: European journal of haematology Issue: Volume 103:Number 4(2019) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Low‐dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD‐FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience. Issue 2 (12th March 2019) Authors: Herishanu, Yair; Tadmor, Tamar; Braester, Andrei; Bairey, Osnat; Aviv, Ariel; Rahimi‐Levene, Naomi; Fineman, Riva; Levi, Itai; Yuklea, Mona; Ruchlemer, Rosa; Shvidel, Lev; Polliack, Aaron Journal: Hematological oncology Issue: Volume 37:Issue 2(2019) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia. (July 2019) Authors: Tadmor, Tamar; Levy, Ilana; Herishanu, Yair; Goldschmidt, Neta; Bairey, Osnat; Yuklea, Mona; Shvidel, Lev; Fineman, Riva; Aviv, Ariel; Ruchlemer, Rosa; Braester, Andrei; Dally, Najib; Rouvio, Ory; Shaulov, Adir; Greenbaum, Uri; Inbar, Michal; Polliack, Aaron Journal: Leukemia research Issue: Volume 82(2019) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Richter's transformation to diffuse large B‐cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group. Issue 11 (2nd September 2014) Authors: Tadmor, Tamar; Shvidel, Lev; Bairey, Osnat; Goldschmidt, Neta; Ruchlemer, Rosa; Fineman, Riva; Rahimi‐Levene, Naomi; Herishanu, Yair; Yuklea, Mona; Arad, Ariela; Aviv, Ariel; Polliack, Aaron; On behalf of the Israeli CLL Study Group Journal: American journal of hematology Issue: Volume 89:Issue 11(2014:Nov.) Page Start: E218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis. Issue 10 (19th February 2013) Authors: Tadmor, Tamar; Shvidel, Lev; Aviv, Ariel; Ruchlemer, Rosa; Bairey, Osnat; Yuklea, Mona; Herishanu, Yair; Braester, Andre; Levene, Naomi; Vernea, Fiona; Ben‐Ezra, Jonathan; Bejar, Jacob; Polliack, Aaron; on behalf of the Israeli CLL Study Group Journal: Cancer Issue: Volume 119:Issue 10(2013) Page Start: 1853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: A study of 176 patients with prognostic implications. Issue 10 (19th February 2013) Authors: Tadmor, Tamar; Shvidel, Lev; Aviv, Ariel; Ruchlemer, Rosa; Bairey, Osnat; Yuklea, Mona; Herishanu, Yair; Braester, Andre; Levene, Naomi; Vernea, Fiona; Ben‐Ezra, Jonathan; Bejar, Jacob; Polliack, Aaron Journal: Cancer Issue: Volume 119:Issue 10(2013) Page Start: 1853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗